Pfizer is voluntarily recalling Accuretic tablets distributed by the company as well as two generics by Greenstone due to the presence of a nitrosamine, N-nitroso-quinapril, above the acceptable level.
- Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets
- Pfizer Inc. rose 0.1% in postmarket trading to $54.25 as of 4:39 p.m. New York time
- The average 12-month price target of $59.36 is 9.4% above the current price
- 14 buys, 13 holds, 1 sells
To view the source of this information, click here
To contact the ...